Medications and dosages used in medical assistance in dying : a cross-sectional study

Article indépendant

STUKALIN, Igor | OLAIYA, Oluwatobi R. | NAIK, Viren | WIEBE, Ellen | KEKEWICH, Mike | KELLY, Michaela | WILDING, Laura | HALKO, Roxanne | OCZKOWSKI, Simon

Background: There is little evidence describing the technical aspects of medical assistance in dying (MAiD) in Canada, such as medications, dosages and complications. Our objective was to describe clinical practice in providing MAiD in Ontario and Vancouver, Canada, and explore relations between medications used, time until death and complications. Methods: We conducted a retrospective cohort study of a sample of adult (age = 18 yr) patients who received MAiD in Ontario between 2016 and 2018, and patients who received MAiD in 1 of 3 Canadian academic hospitals (in Hamilton and Ottawa, Ontario, and Vancouver, British Colombia) between 2019 and 2020. We used de-identified data for 2016–2018 from the Office of the Chief Coroner for Ontario MAiD Database and chart review data for 2019–2020 from the 3 centres. We used multivariable parametric survival analysis to identify relations between medications, dosages and time from procedure start until death. Results: The sample included 3557 patients (1786 men [50.2%] and 1770 women [49.8%] with a mean age of 74 [standard deviation 13] yr). The majority of patients (2519 [70.8%]) had a diagnosis of cancer. The medications most often used were propofol (3504 cases [98.5%]), midazolam (3251 [91.4%]) and rocuronium (3228 [90.8%]). The median time from the first injection until death was 9 (interquartile range 6) minutes. Standard-dose lidocaine (40–60 mg) and high-dose propofol (> 1000 mg) were associated with prolonged time until death (prolonged by a median of 1 min and 3 min, respectively). Complications occurred in 41 cases (1.2%), mostly related to venous access or need for administration of a second medication. Interpretation: In a large sample of patients who died with medical assistance, certain medications were associated with small differences in time from injection to death, and complications were rare. More research is needed to identify the medication protocols that predict outcomes consistent with patient and family expectations for a medically assisted death.

http://dx.doi.org/10.9778/cmajo.20200268

Voir la revue «CMAJ open, 10»

Autres numéros de la revue «CMAJ open»

Consulter en ligne

Suggestions

Du même auteur

Medications and dosages used in medical assis...

Article | STUKALIN, Igor | CMAJ open | n°1 | vol.10

Background: There is little evidence describing the technical aspects of medical assistance in dying (MAiD) in Canada, such as medications, dosages and complications. Our objective was to describe clinical practice in providing MA...

How we can improve the quality of care for pa...

Article indépendant | OCZKOWSKI, Simon Jw | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

CONTEXT: Since Canada decriminalized medical assistance in dying (MAID) in 2015, clinicians and organizations have developed policies and protocols to implement assisted dying in clinical practice. Five years on, there is little c...

How we can improve the quality of care for pa...

Article indépendant | OCZKOWSKI, Simon Jw | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

CONTEXT: Since Canada decriminalized medical assistance in dying (MAID) in 2015, clinicians and organizations have developed policies and protocols to implement assisted dying in clinical practice. Five years on, there is little c...

De la même série

Physician perceptions of restrictive visitor ...

Article indépendant | WENTLANDT, Kirsten | CMAJ open | n°1 | vol.11

Background: Little is understood of the consequences of restrictive visitor policies that were implemented in hospitals to minimize risk of infection during the COVID-19 pandemic. The objective of this study was to describe physic...

Location of death among children with life-th...

Article indépendant | WIDGER, Kimberley | CMAJ open | n°2 | vol.11

BACKGROUND: Patterns in location of death among children with life-threatening conditions (e.g., cancer, genetic disorders, neurologic conditions) may reveal important inequities in access to hospital and community support service...

Physician home visits to rostered patients du...

Article indépendant | SCOTT, Mary M. | CMAJ open | n°4 | vol.11

Background: Physician home visits are associated with better health outcomes, yet most patients near the end of life never receive such a visit. Our objectives were to describe the receipt of physician home visits during the last ...

Providing palliative and end-of-life care in ...

Article indépendant | SHAMON, Sandy | CMAJ open | n°4 | vol.11

BACKGROUND: A disproportionate number of COVID-19-related deaths in Canada occurred in long-term care homes, affecting residents, families and staff alike. This study explored the experiences of long-term care clinicians with resp...

Medications and dosages used in medical assis...

Article indépendant | STUKALIN, Igor | CMAJ open | n°1 | vol.10

Background: There is little evidence describing the technical aspects of medical assistance in dying (MAiD) in Canada, such as medications, dosages and complications. Our objective was to describe clinical practice in providing MA...

Chargement des enrichissements...